Hyprevention
New York, US · Founded 2021 · Delaware corporation
Hyprevention develops STRUTPLASTY, a technology combining PEEK implantable devices with PMMA bone cement to reinforce bones weakened by osteoporosis or cancer. The products are designed to treat fractures and help prevent new ones.
Founders & leadership
CV
Cecile VienneyNamed on SEC filing
BL
Brandford LuNamed on SEC filing
KL
Kathryn LarsonNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$16.1M disclosed across 1 round · 2024
▶$16.1MraisedMay 2024 · 42 investors · Other Health CareRule 506(b)
▶$16.1MraisedMay 2024 · 42 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Cecile VienneyDirector
- Brandford LuDirector
- Kathryn LarsonDirector
- Offering amount
- $16.1M
- Amount sold
- $16.1M
- First sale
- Apr 2024
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlapSocio Labs7 shared keywords
Stratusmedical7 shared keywordsStratus Medical develops the NIMBUS RF multitined expandable electrode, a medical device used for radiofrequency ablation and neurotomy to treat chronic pain in areas such as the hip, lumbar spine, sacroiliac joint, knee, and cervical nerves. The company targets interventional pain physicians and provides clinical evidence and procedural training for its RF technology.
Modmed7 shared keywordsModMed builds specialty-specific electronic health record (EMA/gGastro) and practice management software with AI tools for clinical documentation, scheduling, billing, and claims processing. It serves medical practices across specialties including dermatology, gastroenterology, ophthalmology, orthopedics, urology, and others.
Companies competing with Hyprevention for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Hyprevention do?
- Hyprevention develops STRUTPLASTY, a technology combining PEEK implantable devices with PMMA bone cement to reinforce bones weakened by osteoporosis or cancer. The products are designed to treat fractures and help prevent new ones.
- How much funding has Hyprevention raised?
- Hyprevention has disclosed $16.1M raised across 1 round.
- Where is Hyprevention headquartered?
- Hyprevention is headquartered in New York, US.